Anahita H. Sharma, Burke W. Lawlor, Jason Y. Wang, Y. Sharma, S. Sengupta, P. Fernandes, Fatima Zulqarnain, Eve May, S. Syed, Donald E. Brown
{"title":"Deep Learning for Predicting Pediatric Crohn's Disease Using Histopathological Imaging","authors":"Anahita H. Sharma, Burke W. Lawlor, Jason Y. Wang, Y. Sharma, S. Sengupta, P. Fernandes, Fatima Zulqarnain, Eve May, S. Syed, Donald E. Brown","doi":"10.1109/sieds55548.2022.9799299","DOIUrl":null,"url":null,"abstract":"The current gold standard for Crohn's disease diagnosis involves the examination of biopsied tissue by a trained physician. However, endoscopic images and histological features are only evident when the appropriate biopsy site is chosen and the image is of high quality [1]. Thus, to prevent delayed diagnoses or reclassifications over time, additional tools to reinforce pathologists' diagnoses are necessary. Recent studies have showcased successful applications of deep learning for developing whole-slide classifications of digital histology images. In this study, we developed a patch-level image classification model for prediction of Crohn's disease using a convolutional neural network. This study obtained data from two different hospitals: INOVA and Cincinnati Children's Hospital Medical Center (CCHMC). When trained and validated on the same data set, our INOVA and CCHMC models achieved validation accuracies of 84.6 % and 93.9 %, respectively. However, the models performed poorly when trained on data from one site and tested on data from the other site. To investigate this issue, we built an additional patch-level model that was able to predict hospital source of the biopsy with 99 % accuracy. These results suggest the presence of site-specific artifacts which are detectable by machine learning models. We reduced the effects of these artifacts using color-normalization, image cropping, and other transformations, lowering site-predictive accuracy to 74%. Therefore, we suggest further works investigate reasons for inter-site biopsy differences such that site-generalizable, histopathological deep learning models can be developed.","PeriodicalId":286724,"journal":{"name":"2022 Systems and Information Engineering Design Symposium (SIEDS)","volume":"113 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 Systems and Information Engineering Design Symposium (SIEDS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/sieds55548.2022.9799299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The current gold standard for Crohn's disease diagnosis involves the examination of biopsied tissue by a trained physician. However, endoscopic images and histological features are only evident when the appropriate biopsy site is chosen and the image is of high quality [1]. Thus, to prevent delayed diagnoses or reclassifications over time, additional tools to reinforce pathologists' diagnoses are necessary. Recent studies have showcased successful applications of deep learning for developing whole-slide classifications of digital histology images. In this study, we developed a patch-level image classification model for prediction of Crohn's disease using a convolutional neural network. This study obtained data from two different hospitals: INOVA and Cincinnati Children's Hospital Medical Center (CCHMC). When trained and validated on the same data set, our INOVA and CCHMC models achieved validation accuracies of 84.6 % and 93.9 %, respectively. However, the models performed poorly when trained on data from one site and tested on data from the other site. To investigate this issue, we built an additional patch-level model that was able to predict hospital source of the biopsy with 99 % accuracy. These results suggest the presence of site-specific artifacts which are detectable by machine learning models. We reduced the effects of these artifacts using color-normalization, image cropping, and other transformations, lowering site-predictive accuracy to 74%. Therefore, we suggest further works investigate reasons for inter-site biopsy differences such that site-generalizable, histopathological deep learning models can be developed.